Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin

Rebecca Dowey, Joby Cole, A A Roger Thompson, Chenghao Huang, Jacob Whatmore, Ahmed Iqbal, Kirsty L Bradley, Joanne McKenzie, Rebecca C Hull, Allan Lawrie, Alison M Condliffe, Endre Kiss-Toth, Ian Sabroe, Lynne R Prince
doi: https://doi.org/10.1101/2021.08.24.21262336

Article usage

Article usage: August 2021 to June 2025

AbstractFullPdf
Aug 2021549551
Sep 20218466570
Oct 20211112246
Nov 2021921229
Dec 2021632313
Jan 202243238
Feb 2022391012
Mar 202243105
Apr 202249412
May 202238118
Jun 202241017
Jul 20223108
Aug 202232116
Sep 202235417
Oct 202231010
Nov 202226013
Dec 202219120
Jan 202318315
Feb 202319215
Mar 202316014
Apr 202320114
May 202319119
Jun 20231049
Jul 20239115
Aug 2023151214
Sep 202322417
Oct 202314017
Nov 20232209
Dec 20231725
Jan 202411114
Feb 20249120
Mar 20248024
Apr 20248313
May 20241116
Jun 202416114
Jul 202417210
Aug 20243075
Sep 202419310
Oct 20241547
Nov 20241748
Dec 202415119
Jan 20251625
Feb 2025222211
Mar 202529279
Apr 202529717
May 202517149
Jun 20251699
Back to top
Posted August 26, 2021.
Download PDF
Data/Code
Email
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin
Rebecca Dowey, Joby Cole, A A Roger Thompson, Chenghao Huang, Jacob Whatmore, Ahmed Iqbal, Kirsty L Bradley, Joanne McKenzie, Rebecca C Hull, Allan Lawrie, Alison M Condliffe, Endre Kiss-Toth, Ian Sabroe, Lynne R Prince
medRxiv 2021.08.24.21262336; doi: https://doi.org/10.1101/2021.08.24.21262336
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area